Literature DB >> 29856563

The schizophrenia spectrum anhedonia paradox.

Gregory P Strauss1, Alex S Cohen2.   

Abstract

Entities:  

Year:  2018        PMID： 29856563      PMCID： PMC5980495          DOI： 10.1002/wps.20529

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

Review 1.  Primary and secondary hypohedonia.

Authors:  P E Meehl
Journal:  J Abnorm Psychol       Date:  2001-02

2.  On "risk" and reward: investigating state anhedonia in psychometrically defined schizotypy and schizophrenia.

Authors:  Alex S Cohen; Dallas A Callaway; Gina M Najolia; Jeff T Larsen; Gregory P Strauss
Journal:  J Abnorm Psychol       Date:  2011-12-12

3.  Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.

Authors:  Georg Juckel; Florian Schlagenhauf; Michael Koslowski; Dimitri Filonov; Torsten Wüstenberg; Arno Villringer; Brian Knutson; Thorsten Kienast; Jürgen Gallinat; Jana Wrase; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2006-05-24       Impact factor: 4.530

4.  The course of anhedonia during 10 years of schizophrenic illness.

Authors:  Ellen S Herbener; Martin Harrow
Journal:  J Abnorm Psychol       Date:  2002-05

5.  Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies.

Authors:  Alex S Cohen; Kyle S Minor
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

Review 6.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

Review 7.  Depression, stress, and anhedonia: toward a synthesis and integrated model.

Authors:  Diego A Pizzagalli
Journal:  Annu Rev Clin Psychol       Date:  2014       Impact factor: 18.561

8.  Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-Analysis.

Authors:  Joaquim Radua; André Schmidt; Stefan Borgwardt; Andreas Heinz; Florian Schlagenhauf; Philip McGuire; Paolo Fusar-Poli
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596
  8 in total
  7 in total

1.  Expanding the positivity offset theory of anhedonia to the psychosis continuum.

Authors:  Marcel Riehle; Matthias Pillny; Tania M Lincoln
Journal:  Schizophrenia (Heidelb)       Date:  2022-05-03

Review 2.  Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits.

Authors:  Sugai Liang; Yue Wu; Li Hanxiaoran; Andrew J Greenshaw; Tao Li
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-07       Impact factor: 2.989

Review 3.  A meta-analysis of self-reported anticipatory and consummatory pleasure in the schizophrenia-spectrum.

Authors:  Katherine Frost Visser; Hannah C Chapman; Ivan Ruiz; Ian M Raugh; Gregory P Strauss
Journal:  J Psychiatr Res       Date:  2019-11-14       Impact factor: 4.791

4.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

5.  Alterations in Emotional Diversity Correspond With Increased Severity of Attenuated Positive and Negative Symptoms in the Clinical High-Risk Syndrome.

Authors:  Zachary Anderson; Tina Gupta; William Revelle; Claudia M Haase; Vijay A Mittal
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

6.  Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis.

Authors:  Koen Demyttenaere; Elizabeth Anthonis; Károly Acsai; Christoph U Correll
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 4.157

7.  Spanish validation of the self-evaluation of negative symptoms scale SNS in an adolescent population.

Authors:  Juan F Rodríguez-Testal; Salvador Perona-Garcelán; Sonia Dollfus; María Valdés-Díaz; Jesús García-Martínez; Miguel Ruíz-Veguilla; Cristina Senín-Calderón
Journal:  BMC Psychiatry       Date:  2019-10-29       Impact factor: 3.630
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.